Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
141.03
+6.24 (4.63%)
At close: Nov 4, 2026, 4:00 PM EST
141.05
+0.02 (0.01%)
Pre-market: Nov 5, 2026, 4:48 AM EST
Encompass Health Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Encompass Health stock has a consensus rating of "Strong Buy" and an average price target of $156.08. The average 1-year stock price forecast is 10.67% higher than the current stock price, while the lowest is $142 (+0.69%) and the highest is $177 (+25.51%).
Price Target: $156.08 (+10.67%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $152 → $177 | Buy | Maintains | $152 → $177 | +25.51% | Nov 2, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $140 → $155 | Buy | Maintains | $140 → $155 | +9.91% | Nov 2, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $140 → $150 | Buy | Maintains | $140 → $150 | +6.36% | Oct 30, 2026 |
| UBS | UBS | Buy Reiterates $155 → $165 | Buy | Reiterates | $155 → $165 | +17.00% | Oct 30, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $147 → $150 | Buy | Reiterates | $147 → $150 | +6.36% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
6.48B
from 5.94B
Increased by 9.10%
Revenue Next Year
7.02B
from 6.48B
Increased by 8.38%
EPS This Year
6.28
from 5.45
Increased by 15.22%
EPS Next Year
6.89
from 6.28
Increased by 9.68%
EPS and Forward PE are based on non-GAAP adjusted numbers.